The Soleo Health Denver AIS, located at 9250 East Costilla Avenue, Suite 440, Greenwood Village, CO 80112, 303.968.1915, is ...

Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is a progressive or relapsing neuropathy likely caused by an autoimmune attack on the peripheral nerves. A number of treatment ...

Initiation of a single, two-part, pivotal Phase 3 trial of DNTH103 in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) anticipated by YE’24 Phase 2 MaGic trial of DNTH103 in generalized ...

PORTLAND, OR, UNITED STATES, January 6, 2025 /EINPresswire / -- The global immunoglobulin market is experiencing significant growth, driven by the increasing prevalence of immune-related diseases and ...

Immunovant, Inc. (NASDAQ:IMVT – Get Free Report)’s share price gapped down prior to trading on Friday . The stock had previously closed at $25.19, but opened at $24.52. Immunovant shares last traded ...

Netherlands biotech Argenx has a second FDA approval for its FcRn inhibitor Vyvgart Hytrulo, adding a new indication in chronic inflammatory demyelinating polyneuropathy (CIDP) for a drug that it ...

Korean biotech firms anticipate significant developments in FDA approvals and clinical trials Innovations in medical research ...

Immunovant, Inc. (NASDAQ:IMVT – Get Free Report) traded up 4.1% during mid-day trading on Tuesday . The company traded as high as $24.87 and last traded at $24.87. 67,350 shares traded hands during ...

Soleo Health has opened a new ambulatory infusion suite in the metro Denver area to complement its existing home infusion service offerings.

Halozyme provides subcutaneous drug delivery solutions, with several major new products recently approved. Click here to find ...

The DOT said it is currently investigating other airlines for unrealistic flight schedules that cause chronic delays. “Illegal chronic flight delays make flying unreliable for travelers.